NCT03002389 Hyperpolarized Xenon-129 MRI: a New Multi-dimensional Biomarker to Determine Pulmonary Physiologic Responses to COPD Therapeutics Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02999685 Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients Status COMPLETED Phase NA
NCT02986321 A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPD Status COMPLETED Phase PHASE2
NCT02978703 EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in Greece Status COMPLETED Phase N/A
NCT02975843 Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients Status COMPLETED Phase PHASE1
NCT02972775 15-year Mortality After Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT02972476 Microbiome Use to Stratify Use of Inhaled Corticosteroids: MUSIC Trial Status COMPLETED Phase PHASE4
NCT02968914 Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02967406 Impact of Lifestyle Modification on the Development of Dementia, Chronic Kidney Disease, Diabetes, Chronic Obstructive Pulmonary Disease, Cancers and Cardiovascular Disease in a Thai General Population Status ACTIVE_NOT_RECRUITING Phase NA
NCT02964117 Associations Between Air Pollutants Exposures and Respiratory System Study Status COMPLETED Phase N/A
NCT02955108 The Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory Diseases Status COMPLETED Phase NA
NCT02951312 Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02948582 Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT02941679 Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients Status UNKNOWN Phase PHASE3